Development and Evaluation of Nanoemulsifying Preconcentrate of Curcumin for Colon Delivery

The present study aimed to develop and optimize a nanoemulsifying preconcentrate formulation of curcumin with good emulsification ability and optimal globule size, for controlled targeting in colon. Content of formulation variables, namely, X1 (Peceol), X2 (Cremophor-EL), and X3 (Transcutol HP), wer...

Full description

Saved in:
Bibliographic Details
Main Authors: Jyoti Wadhwa, Abhay Asthana, Gyati Shilakari, Arun Kumar Chopra, Ranjit Singh
Format: Article
Language:English
Published: Wiley 2015-01-01
Series:The Scientific World Journal
Online Access:http://dx.doi.org/10.1155/2015/541510
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832559173919834112
author Jyoti Wadhwa
Abhay Asthana
Gyati Shilakari
Arun Kumar Chopra
Ranjit Singh
author_facet Jyoti Wadhwa
Abhay Asthana
Gyati Shilakari
Arun Kumar Chopra
Ranjit Singh
author_sort Jyoti Wadhwa
collection DOAJ
description The present study aimed to develop and optimize a nanoemulsifying preconcentrate formulation of curcumin with good emulsification ability and optimal globule size, for controlled targeting in colon. Content of formulation variables, namely, X1 (Peceol), X2 (Cremophor-EL), and X3 (Transcutol HP), were optimized by Box-Behnken design of experiments for its impact on mean globule size (Y1), emulsification time (Y2), and time required for drug release (85%) in phosphate buffer (pH 7.2), t85% (Y3). Transmission electron micrographs confirmed that there is no coalescence among globules, with size range concordant with the globule size analysis by dynamic light scattering technique (100 nm). 3D plots indicated that concentration of formulation ingredients significantly influences the formulation properties (globule size, emulsification time, and drug release). In vitro release profile (in phosphate buffer; pH 7.2) represents the fact that more than 50% of the drug was released within initial 15 min whereas in vivo release showed limited systemic absorption (Cmax 200 ng/mL) of curcumin. Stability study ensures the protection of drug in alkaline media which may further confirm the localised delivery of drug to colonic region. Study demonstrated that the nanoemulsifying preconcentrate can be a promising system for the colon specific delivery of curcumin to treat local pathologies.
format Article
id doaj-art-dbeb518c61a345da812d5a66dae2fcc9
institution Kabale University
issn 2356-6140
1537-744X
language English
publishDate 2015-01-01
publisher Wiley
record_format Article
series The Scientific World Journal
spelling doaj-art-dbeb518c61a345da812d5a66dae2fcc92025-02-03T01:30:45ZengWileyThe Scientific World Journal2356-61401537-744X2015-01-01201510.1155/2015/541510541510Development and Evaluation of Nanoemulsifying Preconcentrate of Curcumin for Colon DeliveryJyoti Wadhwa0Abhay Asthana1Gyati Shilakari2Arun Kumar Chopra3Ranjit Singh4M. M. College of Pharmacy, M. M. University, Mullana, Ambala 133207, IndiaM. M. College of Pharmacy, M. M. University, Mullana, Ambala 133207, IndiaM. M. College of Pharmacy, M. M. University, Mullana, Ambala 133207, IndiaInternational Institute of Pharmaceutical Sciences, Jhundpur, Sonepat 131023, IndiaGovernment College of Pharmacy, Rohru, Shimla 171207, IndiaThe present study aimed to develop and optimize a nanoemulsifying preconcentrate formulation of curcumin with good emulsification ability and optimal globule size, for controlled targeting in colon. Content of formulation variables, namely, X1 (Peceol), X2 (Cremophor-EL), and X3 (Transcutol HP), were optimized by Box-Behnken design of experiments for its impact on mean globule size (Y1), emulsification time (Y2), and time required for drug release (85%) in phosphate buffer (pH 7.2), t85% (Y3). Transmission electron micrographs confirmed that there is no coalescence among globules, with size range concordant with the globule size analysis by dynamic light scattering technique (100 nm). 3D plots indicated that concentration of formulation ingredients significantly influences the formulation properties (globule size, emulsification time, and drug release). In vitro release profile (in phosphate buffer; pH 7.2) represents the fact that more than 50% of the drug was released within initial 15 min whereas in vivo release showed limited systemic absorption (Cmax 200 ng/mL) of curcumin. Stability study ensures the protection of drug in alkaline media which may further confirm the localised delivery of drug to colonic region. Study demonstrated that the nanoemulsifying preconcentrate can be a promising system for the colon specific delivery of curcumin to treat local pathologies.http://dx.doi.org/10.1155/2015/541510
spellingShingle Jyoti Wadhwa
Abhay Asthana
Gyati Shilakari
Arun Kumar Chopra
Ranjit Singh
Development and Evaluation of Nanoemulsifying Preconcentrate of Curcumin for Colon Delivery
The Scientific World Journal
title Development and Evaluation of Nanoemulsifying Preconcentrate of Curcumin for Colon Delivery
title_full Development and Evaluation of Nanoemulsifying Preconcentrate of Curcumin for Colon Delivery
title_fullStr Development and Evaluation of Nanoemulsifying Preconcentrate of Curcumin for Colon Delivery
title_full_unstemmed Development and Evaluation of Nanoemulsifying Preconcentrate of Curcumin for Colon Delivery
title_short Development and Evaluation of Nanoemulsifying Preconcentrate of Curcumin for Colon Delivery
title_sort development and evaluation of nanoemulsifying preconcentrate of curcumin for colon delivery
url http://dx.doi.org/10.1155/2015/541510
work_keys_str_mv AT jyotiwadhwa developmentandevaluationofnanoemulsifyingpreconcentrateofcurcuminforcolondelivery
AT abhayasthana developmentandevaluationofnanoemulsifyingpreconcentrateofcurcuminforcolondelivery
AT gyatishilakari developmentandevaluationofnanoemulsifyingpreconcentrateofcurcuminforcolondelivery
AT arunkumarchopra developmentandevaluationofnanoemulsifyingpreconcentrateofcurcuminforcolondelivery
AT ranjitsingh developmentandevaluationofnanoemulsifyingpreconcentrateofcurcuminforcolondelivery